High-risk HPV persistent infection is a high risk factor of female lower reproductive tract cancer.Due to the deep anatomy of the female lower reproductive tract and the vaginal stump retraction after hysterectomy, most patients with HPV infection have no obvious clinical symptoms, so it is more difficult to find, and the treatment is more difficult.The popularity of thinprep cytologic test (TCT) and human papilloma virus (HPV) screening is conducive to the early detection of HPV infection.At present, there are no precise clinical guidelines on the prevention and treatment of HPV infection. Common treatment methods include surgical treatment, physical therapy, local medication, etc., and preoperative vaginal condition assessment is required if necessary.This paper aims to explore the feasibility of prevention of HPV infection after cervical / total hysterectomy based on previous studies.In order to provide new ideas and methods for the prevention and treatment of HPV infection, especially for the prevention and treatment of traditional Chinese medicine.

Chen Ying, He Fengjie. Feasibility Study of Fengxiang Lotion on Prevention and Treatment of HPV Infection. Frontiers in Medical Science Research (2022) Vol. 4, Issue 13: 7-11. https://doi.org/10.25236/FMSR.2022.041302.

[1] Guan P, Howell-Jones R, Li N, et al.  Human papillomavirus types in 115, 789 HPV-positive women: a meta-analysis from cervical infection to cancer[J]. Int J Cancer,2012, 131( 10) : 2349-2359. 

[2] Lv Xiaodong, Yang Junfang, Zhang Kun. Analysis of the clinical features of residual vaginal intraepithelial neoplasia [J]. Cancer progression, 2020,18 (16): 1631-1633 + 1679.

[3] Xu Ying, Li Zhonan, Chen Yi, et al. Clinical analysis of 56 cases of vaginal intraepithelial neoplasia after total hysterectomy [J]. Journal of Shanghai Jiao Tong University (Medical edition), 2017,37 (5): 661-665.

[4] Liao Qingping. Female evaluation of vaginal and vaginal microecology [J]. Journal of Practical Obstetrics and Gynecology, 2010,26 (2): 81-83.

[5] Zhu Chongyun. Vaginal microecological characteristics and influencing factors [J]. Maternal and Child Health Care in China, 2012,27 (5): 789-791.

[6] Lee JE, Lee S, Lee H, et al. Association of the vaginal microbiota with human papillomavirus infection in a korean twin cohort[J]. PLoS One, 2013, 8(5): e63514

[7] Liang Y, Chen M, Qin L, et al. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia[J]. Infect Agents Cancer, 2019, 14: 29

[8] Liang Yuejuan, Zeng Yue, Chen Mengjie, et al. Study on the correlation of vaginal microecology with CIN and HPV infection [J]. Journal of Guangxi Medical University, 2019,36 (11): 1751-1755.

[9] He Fengjie, Wu Keming. Clinical Obstetrics and Gynecology of Traditional Chinese and Western Medicine [M]. Beijing: China Medical Science and Technology Press, 2012:163.

[10] Pan Chaojian. Observation of the clinical efficacy of traditional Chinese medicine granule "Shengyu No.1" to promote the healing of vaginal stump after total uterine resection [D]. Beijing: Beijing University of Traditional Chinese Medicine.2014. 

[11] Zhang Fengchun, Chen Yunfeng, Su Yanzhen. Enhanced effect of diirone on macrophage immune activity [J]. Chinese Pharmaceutical Journal, 1998,33 (9): 532-535.

[12] Zhou Erfu. Modern pharmacological and common clinical compatibility analysis of desone [J]. Modern drug application in China, 2014,8 (3): 238-239.

[13] Luo Hongmei, Ma Yun Shu, Jin'e, Zhang Guihua, Kang Shaojian. Percutaneous protonic effect of clove volatile oil on listrazine phosphate patch [J]. Chinese Journal of Experimental Formulology, 2012,18 (11): 40-42.

[14] Beauty, Zhu Yimin, Luo Jing, et al. Progress in the chemical composition, efficacy and clinical application of clove [J]. Chinese Journal of Experimental Prescription Medicine, 2019,25 (15): 222-227.

[15] Qin Xiaoyan, Hu Zhen, Zhang Huamei, and so on. Progress in the pharmacological effects and related mechanisms of snake bed element [J]. Tianjin Traditional Chinese Medicine, 2018,35 (11): 877-880.

[16] Li Ka-shing, Wu LAN, CAI Tong-kai, et al. Progress in the chemical composition and pharmacological effects of cypress chinensis [J]. Journal of Pharmaceutical Practice, 2018,36 (5): 389-391,398.

[17] Zhao Runqin, Zhang Yunfei, Feng Cheng, et al. Progress in chemical composition and pharmacological effects of Cocscomb [J]. Traditional Chinese Medicine Information, 2017,34 (3): 129-131.

[18] Li Fei, Zheng Wei, Zhu Hongli, et al. Observation of the efficacy of Fengxiang vector bolt and Opin bolt in treating cervical HR-HPV infection [J]. Liaoning Traditional Chinese Medicine Journal, 2017,44 (8): 1649-1650.

[19] Yan Ying, Zhang Han, Wu Lingling, Ha Xiaolian. Progress in modern research on TCM in improving vaginal microecology [J]. Hunan Journal of Traditional Chinese Medicine, 2015,31 (07): 188-190.

[20] Li Xiaoning, Liu Xia, Gui Xiaofeng. Effect of "Fengxiang lotion" on cervical local humoral immunity in high-risk HPV infections and patients with CINI [J]. World Traditional Chinese Medicine, 2017,12 (10): 2301-2305.

[21] Chen Ruiping, Xu Jianping, Li Qing. Human papillomavirus infection and local immune function of cervical cancer [J]. Journal of Practical Medicine, 2011,12 (27): 2 282-2 284.

[22] Vizlor C, Rosato A, Galderazzo F, et al. Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased antitumor cytotoxic T-lymphocyte activity[J].Br J Cancer, 1998, 77(4): 656-662

[23] Wu Yan. Study of Th1 / Th2 cytokines expression levels in cervical cancer patients [J]. Oncology Research and Clinical Research, 2006,18 (5): 310-316.

[24] Li Xiaoning, Wang Ni, He Fengjie. The level of the local vaginal interleukin-10,12 and the intervention effect of Fengxiang lotion in patients with high-risk HPV-infected cervical intraepithelial neoplasia [J]. Guangxi Medicine, 2015,37 (08): 1114-1117.